01 November 2018 1 Min Read
Pfizer is mulling sale of women's health line, insiders say
The move would mean Pfizer would join Allergan and Teva in selling or winding down women’s health portfolios and shifting resources to other areas
Subscribe to our website to read this article and support quality journalism.
If you’ve already subscribed, simply sign in.
Subscribe Sign In